- Fujifilm’s operating income for the 3rd quarter was 87.68 billion yen, which fell short of the estimated 97.49 billion yen.
- Net income for the same period was 71.24 billion yen, slightly below the estimate of 75.81 billion yen.
- Net sales reached 812.77 billion yen, narrowly missing the target of 813.1 billion yen.
- In the nine-month results, the healthcare segment reported an operating income of 32.85 billion yen.
- The materials segment saw an operating income of 59.07 billion yen.
- The business innovation segment contributed 42.76 billion yen in operating income.
- The imaging segment was particularly strong, with an operating income of 115.01 billion yen.
- Research and development expenses totaled 121.46 billion yen.
- The company maintains its year forecast with an operating income of 315.00 billion yen against an estimate of 321.14 billion yen.
- Net income for the year is expected to be 250.00 billion yen, close to the estimate of 250.48 billion yen.
- Projected net sales are 3.15 trillion yen, aligned with estimates.
- The dividend per share is set to be 60.00 yen, slightly above the estimated 59.67 yen.
- Investment community sentiment is positive, with 14 buy ratings, 4 holds, and no sell recommendations.
FUJIFILM Holdings on Smartkarma
On Smartkarma, independent analysts are closely monitoring FUJIFILM Holdings through reports like “Tech Supply Chain Tracker (05-Dec-2024): AI sovereignty.” This report, authored by Tech Supply Chain Tracker, leans bullish on the company. It highlights significant developments such as FUJIFILM Taiwan’s expansion with a new plant in Hsinchu and ASM’s growth near TSMC in Taiwan. The report also discusses China’s export ban on gallium and germanium and its impact on US industries, alongside Marvell’s strong 3Q24 results driven by the high demand for AI silicon.
A look at FUJIFILM Holdings Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
FUJIFILM Holdings Corporation, a company specializing in Imaging, Information, and Document Solutions, has received a mixed outlook based on the Smartkarma Smart Scores. With a Value score of 3, the company is perceived to have moderate attractiveness in terms of its current stock price relative to its intrinsic value. In terms of Dividend and Growth, Fujifilm scored a 2 and 3 respectively, suggesting a moderate performance in dividend distribution and growth potential. Furthermore, the company scored a 3 in both Resilience and Momentum, indicating a stable performance in the face of market challenges and a steady operational momentum.
As a diversified corporation offering a wide range of products including color films, digital cameras, medical equipment, and office services, Fujifilm Holdings is positioned with a balanced outlook across key factors such as value, growth, and resilience. While not excelling in any particular area, the company’s consistent scores across the board suggest a steady and reliable performance in the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
